Bristol-Myers CEO on Delta Variant, Return of Office Workforce

The transcript discusses Bristol Myers Squibb's resilience during the pandemic, highlighting their ability to deliver medicines and adapt to healthcare challenges. It emphasizes the importance of safety measures, vaccination, and mask mandates for workforce health. The company focuses on business development and innovation, particularly in oncology, to maintain competitiveness. Talent acquisition is crucial as they invest in science and expand their workforce.

How has Bristol Myers Squibb managed to maintain its operations during the pandemic?

• By reducing workforce size

• By delivering medicines and launching new ones

• By relying on external partners

• By halting new medicine launches

What measures has Bristol Myers Squibb implemented to ensure workforce safety?

• Weekly health checks

• Mask mandates and social distancing

• Mandatory vaccination

• Remote work only

What is the primary focus of Bristol Myers Squibb's business development strategy?

• Expanding into new markets

• Acquiring smaller companies

• Reducing research costs

• Combining internal research with external innovation

In which area has Bristol Myers Squibb recently strengthened its leadership position?

• Oncology

• Cardiovascular medicines

• Protein synthesis

• Cell therapy

What is a significant challenge Bristol Myers Squibb faces in growing its workforce?

• Lack of funding

• Regulatory hurdles

• Competition for talent

• Limited research facilities

Which areas of science are mentioned as exciting fields for talent competition?

• Biochemistry and pharmacology

• Neuroscience and immunology

• Cell therapy and cardiovascular medicines

• Genetic engineering and virology

What has been a key factor in Bristol Myers Squibb's success in attracting talent?

• Flexible work hours

• High salaries

• International collaborations

• Strong pipeline and quality science